Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (141-150 of 1,315) with videos related to

Pageof 132
Sort By:
Korean Journal of Radiology|November 28, 2023
Understanding the Pathophysiology and Magnetic Resonance Imaging of Multiple Sclerosis and Neuromyelitis Optica Spectrum DisordersLaura Cacciaguerra, Maria A Rocca, Massimo Filippi
The Lancet. Neurology|July 10, 2003
The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosisMassimo Filippi, Maria A Rocca, Giancarlo Comi
Frontiers in Neurology|September 9, 2020
Editorial: Functional and Structural Brain Alterations in Headache: A Trait or a State?Roberta Messina, Peter J Goadsby, Massimo Filippi
Current Opinion in Neurology|May 6, 2014
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?Massimo Filippi, Paolo Preziosa, Maria A Rocca
Expert Review of Neurotherapeutics|July 8, 2021
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?Paolo Preziosa, Massimo Filippi, Maria A Rocca
Current Opinion in Neurology|June 29, 2018
MRI in multiple sclerosis: what is changing?Massimo Filippi, Paolo Preziosa, Maria A Rocca
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 31, 2005
Magnetic resonance imaging monitoring of multiple sclerosis lesion evolutionMatilde Inglese, Robert I Grossman, Massimo Filippi
The Lancet. Neurology|February 21, 2006
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled studyMassimo Filippi, Jerry S Wolinsky, Giancarlo Comi, et al.
Neuroimage|September 18, 2017
Brain mapping in multiple sclerosis: Lessons learned about the human brainMassimo Filippi, Paolo Preziosa, Maria A Rocca
Journal of the Neurological Sciences|September 28, 2007
Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosisNicola De Stefano, Massimo Filippi, Clive Hawkins, et al.
Pageof 132

Showing results (141-150 of 1,315) with videos related to

Sort By:
Pageof 132
Korean Journal of Radiology|November 28, 2023
Understanding the Pathophysiology and Magnetic Resonance Imaging of Multiple Sclerosis and Neuromyelitis Optica Spectrum DisordersLaura Cacciaguerra, Maria A Rocca, Massimo Filippi
The Lancet. Neurology|July 10, 2003
The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosisMassimo Filippi, Maria A Rocca, Giancarlo Comi
Frontiers in Neurology|September 9, 2020
Editorial: Functional and Structural Brain Alterations in Headache: A Trait or a State?Roberta Messina, Peter J Goadsby, Massimo Filippi
Current Opinion in Neurology|May 6, 2014
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?Massimo Filippi, Paolo Preziosa, Maria A Rocca
Expert Review of Neurotherapeutics|July 8, 2021
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?Paolo Preziosa, Massimo Filippi, Maria A Rocca
Current Opinion in Neurology|June 29, 2018
MRI in multiple sclerosis: what is changing?Massimo Filippi, Paolo Preziosa, Maria A Rocca
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 31, 2005
Magnetic resonance imaging monitoring of multiple sclerosis lesion evolutionMatilde Inglese, Robert I Grossman, Massimo Filippi
The Lancet. Neurology|February 21, 2006
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled studyMassimo Filippi, Jerry S Wolinsky, Giancarlo Comi, et al.
Neuroimage|September 18, 2017
Brain mapping in multiple sclerosis: Lessons learned about the human brainMassimo Filippi, Paolo Preziosa, Maria A Rocca
Journal of the Neurological Sciences|September 28, 2007
Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosisNicola De Stefano, Massimo Filippi, Clive Hawkins, et al.
Pageof 132